Author Dreyling, Martin

1 to 6 of 6 Items
  • 2009 Journal Article | 
    ​ ​A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.​
    Martin-Subero, J. I.; Ammerpohl, O.; Bibikova, M.; Wickham-Garcia, E.; Agirre, X.; Alvarez, S. & Brüggemann, M. et al.​ (2009) 
    PloS one4(9) art. e6986​.​ DOI: https://doi.org/10.1371/journal.pone.0006986 
    Details  DOI  PMID  PMC 
  • 2017 Journal Article
    ​ ​Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients​
    Pfreundschuh, M.; Murawski, N.; Zeynalova, S.; Ziepert, M.; Loeffler, M.; Hänel, M. & Dierlamm, J. et al.​ (2017) 
    British Journal of Haematology179(3) pp. 410​-420​.​ DOI: https://doi.org/10.1111/bjh.14860 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma​
    Herfarth, K.; Borchmann, P.; Schnaidt, S.; Hohloch, K.; Budach, V.; Engelhard, M. & Viardot, A. et al.​ (2018) 
    HemaSphere2(6) pp. e160​.​ DOI: https://doi.org/10.1097/HS9.0000000000000160 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial​
    König, L.; Dreyling, M.; Dürig, J.; Engelhard, M.; Hohloch, K. ; Viardot, A. & Witzens-Harig, M. et al.​ (2019) 
    Trials20(1).​ DOI: https://doi.org/10.1186/s13063-019-3614-y 
    Details  DOI 
  • 2022 Journal Article
    ​ ​The EHA Research Roadmap: Malignant Lymphoid Diseases​
    Dreyling, M.; André, M.; Gökbuget, N.; Tilly, H.; Jerkeman, M.; Gribben, J. & Ferreri, A. et al.​ (2022) 
    HemaSphere6(6) art. e726​.​ DOI: https://doi.org/10.1097/HS9.0000000000000726 
    Details  DOI 
  • 2022 Journal Article
    ​ ​First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial​
    Braulke, F.; Zettl, F.; Ziepert, M.; Viardot, A.; Kahl, C.; Prange-Krex, G. & Korfel, A. et al.​ (2022) 
    HemaSphere6(12) art. e808​.​ DOI: https://doi.org/10.1097/HS9.0000000000000808 
    Details  DOI  WoS 

Researcher

Sort

issue date

ASC DESC

Items per Page